These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1715489)
1. Signals for cardiac muscle hypertrophy in hypertension. Kent RL; Mann DL; Cooper G J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S7-13. PubMed ID: 1715489 [TBL] [Abstract][Full Text] [Related]
2. Signals for the remodeling of the cardiac interstitium in systemic hypertension. Weber KT; Brilla CG; Janicki JS J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S14-9. PubMed ID: 1715464 [TBL] [Abstract][Full Text] [Related]
3. Myocardial hypertrophy and cardiac failure: a complex interrelationship. Massie BM Am J Med; 1983 Sep; 75(3A):67-74. PubMed ID: 6226198 [TBL] [Abstract][Full Text] [Related]
4. Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena? Rossi MA; Carillo SV Int J Cardiol; 1991 May; 31(2):133-41. PubMed ID: 1831183 [TBL] [Abstract][Full Text] [Related]
5. Role of the renin-angiotensin system in cardiac hypertrophy. Yamazaki T; Komuro I; Yazaki Y Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588 [TBL] [Abstract][Full Text] [Related]
6. Cardiocyte cytoskeleton in hypertrophied myocardium. Cooper G Heart Fail Rev; 2000 Oct; 5(3):187-201. PubMed ID: 16228904 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of ventricular hypertrophy. Oparil S J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):57B-65B. PubMed ID: 3158693 [TBL] [Abstract][Full Text] [Related]
8. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiological aspects of myocardial hypertrophy. Dhalla NS; Heyliger CE; Beamish RE; Innes IR Can J Cardiol; 1987 May; 3(4):183-96. PubMed ID: 3036324 [TBL] [Abstract][Full Text] [Related]
10. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease. Strauer BE Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004 [TBL] [Abstract][Full Text] [Related]
12. Recuperative potential of cardiac muscle following relief of pressure overload hypertrophy and right ventricular failure in the cat. Coulson RL; Yazdanfar S; Rubio E; Bove AA; Lemole GM; Spann JF Circ Res; 1977 Jan; 40(1):41-9. PubMed ID: 137086 [TBL] [Abstract][Full Text] [Related]
13. The biochemical response of the heart to hypertension and exercise. Wakatsuki T; Schlessinger J; Elson EL Trends Biochem Sci; 2004 Nov; 29(11):609-17. PubMed ID: 15501680 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. Chien KR; Knowlton KU; Zhu H; Chien S FASEB J; 1991 Dec; 5(15):3037-46. PubMed ID: 1835945 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10140-5. PubMed ID: 9707614 [TBL] [Abstract][Full Text] [Related]
16. Effects of pressure- or volume-overload hypertrophy on passive stiffness in isolated adult cardiac muscle cells. Kato S; Koide M; Cooper G; Zile MR Am J Physiol; 1996 Dec; 271(6 Pt 2):H2575-83. PubMed ID: 8997318 [TBL] [Abstract][Full Text] [Related]
17. Catecholamines in cardiac hypertrophy. Scheuer J Am J Cardiol; 1999 Jun; 83(12A):70H-74H. PubMed ID: 10750591 [TBL] [Abstract][Full Text] [Related]
18. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Balakumar P; Jagadeesh G Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208 [TBL] [Abstract][Full Text] [Related]
19. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy. Haddad GE; Coleman BR; Zhao A; Blackwell KN Basic Res Cardiol; 2004 Sep; 99(5):317-27. PubMed ID: 15309409 [TBL] [Abstract][Full Text] [Related]
20. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review. Dahlöf B Drugs; 1988; 35 Suppl 5():6-26. PubMed ID: 2975216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]